Global Professional Diagnostics Market 2016-2020


#867677

86pages

Technavio

$ 2500

In Stock

About Professional Diagnostics

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years.

Technavios analysts forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global professional diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of in-vitro diagnostics (IVD) instruments.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Professional Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Diagnostics
Danaher
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific

Other prominent vendors
A&T Corporation
Menarini Diagnostics
Abaxis
Abcam
Accriva Diagnostics
Acon Laboratories
Affymetrix
Ahram Biosystem
ARKRAY
AsuraGen
Biocartis
Bio-Rad Laboratories
CellaVision
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
Corgenix
DiagCor
Drucker Diagnostics
EKF Molecular Diagnostics
Erba Diagnostics
Green Cross Medis
Helena Laboratories
Hologic
HORIBA
Instrumentation Laboratory
i-Sens
Landwind Medical
Mindray
Nihon Kohden
Nipro Diagnostics
Randox Laboratories
Sekisui Medical
Sienco
Sinduri Biotec
Snibe Diagnostics
Stago
Trivitron Healthcare

Market driver
Growing focus on diagnosing life-threatening conditions boosts POCT segment.
For a full, detailed list, view our report

Market challenge
Industry consolidation posing threat to new entrants.
For a full, detailed list, view our report

Market trend
Renting and leasing of professional diagnostics instruments.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.



Table of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Immunochemistry
Clinical microbiology
POCT
Hematology
Hemostasis
PART 07: Market segmentation by end-user
Hospitals
Diagnostic laboratories
PART 08: Geographical segmentation
Professional diagnostics market in Americas
Professional diagnostics market in EMEA
Professional diagnostics market in APAC
PART 09: Market drivers
Increasing industrial partnerships driving the growth of the market
Growing focus on diagnosing life-threatening conditions boosts POCT segment
Potential opportunities for physician office laboratories (POL)
PART 10: Impact of drivers
PART 11: Market challenges
Professional challenges in clinical microbiology and infectious diseases in Europe
Strained laboratory budgets and lowering reimbursement effecting instrument sales
Industry consolidation posing threat to new entrants
Limitations of closed systems in professional diagnostics testing
PART 12: Impact of drivers and challenges
PART 13: Market trends
Launch of novel tests in lung and colon cancer influencing the market growth of PD devices
Renting and leasing of professional diagnostics instruments
Multiple technologies-based hematology analyzers
Paradigm shift toward focused investments by vendors is increasing the market competition
PART 14: Vendor landscape
Competitive scenario
PART 15: Key vendor analysis
Abbott Diagnostics
Danaher Corporation
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Analysis of other tier-1 companies
Other prominent vendors
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Global professional diagnostics segments analysis 2015
Exhibit 02: Product offerings
Exhibit 03: Global professional diagnostics market overview
Exhibit 04: Global professional diagnostics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Market overview of immunochemistry instruments
Exhibit 07: Classification of immunochemistry market
Exhibit 08: Global immunochemistry market segmentation 2015
Exhibit 09: Global immunochemistry instruments market 2015-2020 ($ billions)
Exhibit 10: Immunochemistry metrics analysis
Exhibit 11: Market overview of clinical microbiology instruments
Exhibit 12: Global clinical microbiology instruments market 2015-2020 ($ millions)
Exhibit 13: Clinical microbiology metrics analysis
Exhibit 14: Market overview of POCT instruments
Exhibit 15: Market share for POCT testing in the US 2015
Exhibit 16: Pros and cons of POCT testing
Exhibit 17: Global POCT instruments market 2015-2020 ($ billions)
Exhibit 18: POCT metrics analysis
Exhibit 19: Market overview of hematology instruments
Exhibit 20: Global hematology instruments market 2015-2020 ($ millions)
Exhibit 21: Hematology metrics analysis
Exhibit 22: Global hematology instruments market 2015-2020 ($ millions)
Exhibit 23: Global hemostasis instruments market 2015-2020 ($ millions)
Exhibit 24: Hemostasis metrics analysis
Exhibit 25: Various types of reference measurement services
Exhibit 26: Hub and Spoke model for reference laboratories
Exhibit 27: Global professional diagnostics market 2015
Exhibit 28: Professional diagnostics market overview in Americas 2015
Exhibit 29: Professional diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 30: Professional diagnostics market overview in EMEA 2015
Exhibit 31: Professional diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 32: Professional diagnostics market overview in APAC 2015
Exhibit 33: Professional diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 34: Strategic initiatives for market growth
Exhibit 35: Impact on key customer categories
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Benefits of renting and leasing of professional diagnostics instruments
Exhibit 38: Focus of companies on investments for revenue growth
Exhibit 39: Competitive structure analysis of global professional diagnostics instruments market 2015
Exhibit 40: Global professional diagnostics market: Competitive landscape 2015
Exhibit 41: Mergers and acquisitions
Exhibit 42: Companies with joint venture agreement
Exhibit 43: Abbott Diagnostics: Strength assessment
Exhibit 44: Abbott Diagnostics: Strategy assessment
Exhibit 45: Abbott Diagnostics: Opportunity assessment
Exhibit 46: Danaher Corporation: Strength assessment
Exhibit 47: Danaher Corporation: Strategy assessment
Exhibit 48: Danaher Corporation: Opportunity assessment
Exhibit 49: Roche Diagnostics: Strength assessment
Exhibit 50: Roche Diagnostics: Strategy assessment
Exhibit 51: Roche Diagnostics: Opportunity assessment
Exhibit 52: Siemens Healthcare: Strength assessment
Exhibit 53: Siemens Healthcare: Strategy assessment
Exhibit 54: Siemens Healthcare: Opportunity assessment
Exhibit 55: Thermo Fisher Scientific: Strength assessment
Exhibit 56: Thermo Fisher Scientific: Strategy assessment
Exhibit 57: Thermo Fisher Scientific: Opportunity assessment
Exhibit 58: Alere company analysis
Exhibit 59: Becton Dickinson company analysis
Exhibit 60: bioMerieux company analysis
Exhibit 61: Sysmex Corporation company analysis
Exhibit 62: Other prominent vendors